Healthy Returns: Why people quit weight loss and diabetes drugs within one year
A new study examines how cost, side effects and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...
Rolling Out12h
The breakthrough medication reshaping diabetes care
Discover how modern diabetes medications offer cardiovascular benefits, transforming diabetes care and improving outcomes worldwide.
Medical News Today9d
Calorie restriction plus common diabetes drug leads to higher remission rates
A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes ...
Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected
Eli Lilly expects to read out results from a study in people with obesity and osteoarthritis of the knee in 2025.
Patients using diabetes apps can miss critical alerts. Here’s how to make sure you’re getting them
These days, many devices are programmed through apps on patients’ phones. But the FDA warns that certain phone settings, such ...
Lilly Forecasts 2025 Profit Largely Above Estimates on Weight-Loss Drug Strength
On an adjusted basis, the U.S. drugmaker expects to earn between $22.50 and $24.00 per share in 2025. Analysts were expecting ...
Whose cardiovascular health do SGLT2, GLP-1 diabetes drugs benefit most?
A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of cardiovascular disease.
Rolling Out13d
How diabetes medications could change stroke prevention
Learn how diabetes medications could revolutionize stroke prevention and enhance heart and brain health with breakthrough ...
Medscape20h
FDA Warns About Diabetes Device Smartphone Alert Settings
The US Food and Drug Administration (FDA) is cautioning patients and caregivers about the potential for not receiving blood ...